University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Etelcalcetide
Status: Red Etranacogene dezaparvovec (Hemgenix®)
Status: Red Etrasimod
Status: Red Everolimus (Afinitor®)

Negative outcome - CDF funded for renal, NET, breast. For hospital use only.
Status: Red Evinacumab (Evkeeza®)
Status: Red Evinacumab (Evkeeza®)
Status: Red Evolocumab

& Homozygous familial hypercholesterola EMIA in line with NHS England SSC 1649

To be used in line with NICE TA
Status: Red Exagamglogene autotemcel (Casgevy®)
NICE TA 1003Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia in people 12 years and over
NICE TA 1044Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over
Status: Amber Exemestane tablets
Status: Green Ezetimibe tablets
Building healthier lives
Back to top